H-89 is a specific adenylyl cyclase inhibitor (DDA) and a cyclic AMP-dependent protein kinase inhibitor. H-89 blocks the action of equine growth hormone on in vitro maturation of equine oocytes. H-89 decreases the gain of excitation-contraction coupling and attenuates calcium sparks in the absence of beta-adrenergic stimulation. H-89 potentiates adipogenesis in 3T3-L1 cells by activating insulin signaling independently of protein kinase A.
S6 Kinase Inhibitors Related Prodcuts:
BI-D1870; AT7867; H-89 2HCl; Staurosporine; Pluripotin; LY-2584702; AT13148; Bosutinib; PF-4708671